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Introduction
The etiology and pathogenesis of JIA are believed to be
influenced by both genetic and environmental factors.
Although several associations between the risk of develop-
ing JIA and gene variants both inside and outside the HLA
region have been confirmed, no studies have examined
associations between non-HLA gene polymorphisms and
the disease outcome.
Objectives
Genes involved in immune regulation and signal transduc-
tion of cytokines were studied. The genes chosen were
previously shown to be associated with JIA in independent
validation studies. They were selected to test the hypoth-
esis that Single Nucleotide Polymorphisms (SNPs)
previously shown to be associated with JIA are also risk
factors for a severe disease outcome.
Methods
A total of 500 children with JIA were included prospec-
tively in a population based Nordic cohort study in
1997-2000. All patients had a recent diagnosis of JIA at
inclusion. Not all centers were able to collect DNA
from patients and at 8 year follow-up DNA was avail-
able from 217 patients. All eight categories of JIA were
represented in the final cohort. Clinical data were col-
lected longitudinally for the first eight years of disease.
Remission was defined according to the preliminary cri-
teria by Wallace et al. 2004. Testing of polymorphisms
was performed using PCR based technology (KASPar
v3.0 & v4.0 SNP Genotyping).
Results
At the eight year follow-up visit 45% of the patients
were in remission, on/off medication. Of the 11 SNPs
examined, significant associations between genotypes
and clinical endpoints were found for WISP3, IL2RA,
STAT4 and VTCN1, although with low level of signifi-
cance, p= 0.02-0.05 (Fisher’s exact test). Carriage of the
A:A genotype of STAT4 was associated with persistently
active disease eight years after disease onset (p=0.03)
with about 7 times increased risk, but was not asso-
ciated with onset type or the use of second line treat-
ment (MTX and/or biologics). The other 7 tested SNPs
were not associated with disease outcome
Conclusion
In a JIA cohort with longitudinally collected data, we
were unable to show robust associations between
selected non-HLA genotypes and disease outcome. Data
were suggestive of associations between STAT4 A:A and
an aggressive course of JIA in which remission were not
achieved at eight year follow-up. This is of interest
because STAT4 mediates the transcription of cytokine
inducible genes and the A:A genotype has previously
been associated with an increased risk of developing JIA.
These findings should be confirmed in larger patient
cohorts.
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Table 1
STAT4_rs3821236 genotype Vs. remission status
Remission (%) No remission (%) Total n.
A:A 1 (13) 7 (87) 8
G:A 37 (56) 30 (44) 67
G:G 47 (41) 68 (59) 115
Fisher’s exact test p = 0.03
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